Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control studySalim Yusuf, Sonia S. Anand, Steven Hawken et al.|The Lancet|2005Cited by 2.9k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialPaul M. Ridker, Hakan Kültürsay, Peter Siostrzonek et al.|The Lancet|2017Cited by 1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialPaul M. Ridker, Patrick Commerford, Jean MacFadyen et al.|The Lancet|2017Cited by 881
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeStuart J. Connolly, Salim Yusuf, Janice Pogue et al.|Circulation|2008Cited by 873